Amy Moran

Assistant Professor

  • 1140 Citations
  • 10 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Amy Moran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Celecoxib Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Enterocytes Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
T-Cell Antigen Receptor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Adenoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 1140 Citations
  • 10 h-Index
  • 15 Article
  • 2 Review article
3 Citations (Scopus)

Late-stage tumor regression after PD-L1 blockade plus a concurrent OX40 agonist

Polesso, F., Weinberg, A. D. & Moran, A., Feb 1 2019, In : Cancer Immunology Research. 7, 2, p. 269-281 13 p.

Research output: Contribution to journalArticle

Neoplasm Antigens
CD8 Antigens
1 Citation (Scopus)

OX40 agonist tumor immunotherapy does not impact regulatory T cell suppressive function

Polesso, F., Sarker, M., Weinberg, A. D., Murray, S. E. & Moran, A. E., Oct 1 2019, In : Journal of Immunology. 203, 7, p. 2011-2019 9 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
4 Citations (Scopus)

Nod2 deficiency augments Th17 responses and exacerbates autoimmune arthritis

Napier, R. J., Lee, E., Vance, E. E., Snow, P. E., Samson, K. A., Dawson, C. E., Moran, A., Stenzel, P., Davey, M., Sakaguchi, S. & Rosenzweig, H., Oct 1 2018, In : Journal of Immunology. 201, 7, p. 1889-1898 10 p.

Research output: Contribution to journalArticle

Th17 Cells
10 Citations (Scopus)

Immunotherapy expands and maintains the function of high-affinity tumor-infiltrating CD8 T cells in situ

Moran, A., Polesso, F. & Weinberg, A. D., Sep 15 2016, In : Journal of Immunology. 197, 6, p. 2509-2521 13 p.

Research output: Contribution to journalArticle

Open Access
Cell- and Tissue-Based Therapy
Tumor Microenvironment
2 Citations (Scopus)

B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells

Dillon, T. J., Takahashi, M., Li, Y., Tavisala, S., Murray, S., Moran, A., Parker, D. & Stork, P., Apr 2013, In : International Immunology. 25, 4, p. 259-269 11 p.

Research output: Contribution to journalArticle

raf Kinases
MAP Kinase Signaling System
T-Cell Antigen Receptor
Thymus Gland